On March 01, 2012, the Food and Drug Administration (FDA) will celebrate the fifth annual Rare Disease Day by hosting a "FDA Rare Disease Patient Advocacy Day" to engage and educate the rare disease community on regulatory processes related to rare diseases.
This meeting is intended to enhance the awareness of the rare disease community as to FDA’s roles and responsibilities in the development of products (drugs, biological products and devices) for the diagnosis, prevention, and/or treatment of rare diseases or conditions.
This educational meeting will consist of live and interactive simultaneous webcast of presentations provided by FDA experts from various Centers and Offices, as well as from outside experts. The interactive meeting will include two general panel discussion sessions, as well as afternoon breakout sessions for more in-depth information on the roles of FDA. In addition, on-site attendees will have an opportunity during lunch to engage with FDA and outside experts in a small group setting.
While attendance is free, registration is required to attend the event.
Register for FDA Rare Disease Patient Advocacy Day
If you need sign language interpretation during this meeting, please contact Megan McNamee at
by February 15, 2012.
Location and Directions:
White Oak Campus
10903 New Hampshire Ave
Silver Spring, MD, 20993
Location, directions, and other information about White Oak
March 01, 2012
Event agenda is in preparation and will be posted prior to the meeting
To connect to the live webcast of the meeting please follow the Connect Pro instructions.
The FDA Rare Disease Patient Advocacy Day is supported by the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the National Organization for Rare Disorders (NORD), and the Genetic Alliance.
The FDA encourages all attendees to also plan on attending the National Institutes of Health (NIH) Rare Disease Day day-long celebration on February 29, 2012.